Otsuka Holdings
4578.T
#630
Rank
ยฃ25.25 B
Marketcap
ยฃ44.99
Share price
0.34%
Change (1 day)
53.50%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2024 (TTM): ยฃ11.53 Billion

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM ) is ยฃ11.41 Billion. In 2023 the company made a revenue of ยฃ11.14 Billion an increase over the revenue in the year 2022 that were of ยฃ10.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ11.53 B3.49%
2023 ยฃ11.14 B3.47%
2022 ยฃ10.76 B8.66%
2021 ยฃ9.91 B0.68%
2020 ยฃ9.84 B0.75%
2019 ยฃ9.77 B5.92%
2018 ยฃ9.22 B12.91%
2017 ยฃ8.17 B-8.18%
2016 ยฃ8.89 B10.16%
2015 ยฃ8.07 B
2013 ยฃ8.58 B-3.06%
2012 ยฃ8.85 B-3.91%
2011 ยฃ9.21 B11.48%
2010 ยฃ8.26 B